Effect of Atropine on Pupil Size and Quality of Vision
Status:
Not yet recruiting
Trial end date:
2023-12-20
Target enrollment:
Participant gender:
Summary
This aims to investigated the short-term (12, 16, and 20 h) effects of 0.01% atropine (0.1
mg/ml) on pupil size and subjective quality of vision in participants with myopia.
Particpants will receive 0.01% atropine one drop to both eyes before bedtime. Baseline
parameters were measured before atropine application. Changes in pupil sizes, under photopic
and mesopic conditions, high-order aberration, and tear meniscus height were observed over
the next day (12, 16, and 20 h).